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Podoconiosis research to implementation: a call for global 
action
Podoconiosis is a form of tropical lymphoedema caused 
by exposure to volcanic soils in people who do not use 
footwear.1,2 The past fifteen years have seen substantial 
progress in podoconiosis research.3,4 We are now 
entering a crucial time marked by the need for increased 
funding both for research and for translation of this 
research into implementation. Together, research and its 
translation will shape a global strategy for podoconiosis 
control and elimination.5,6
There have been several encouraging developments 
in the fight against podoconiosis in recent years. 
National or local programmes for the control and 
elimination of podoconiosis have been initiated in four 
endemic countries (Ethiopia, Uganda, Rwanda, and 
Cameroon). Nationwide mapping of podoconiosis has 
been completed in three countries,6 and at least three 
countries have achieved impressive improvements in 
surveillance systems. Morbidity management services 
have also been expanded in Ethiopia.5
Substantial progress has also been made in terms 
of research. Genome wide association studies have 
identified genetic susceptibility loci.7 Mineralogical 
studies have linked specific minerals (smectite, mica, 
and quartz) within the soil with a high prevalence 
of podoconiosis.8 Social and economic studies have 
quantified the stigma,9 discrimination, and economic 
impact of the disease.10 Developments in geostatistical 
and machine learning approaches have facilitated 
disease distribution mapping and estimation of the 
burden of disease.11 Additionally, the effect of a simple 
lymphoedema management package on the frequency 
of acute attacks has been documented.12
Despite this progress in generating evidence, translation 
into policy and practice at the global level is poor. Four 
clear barriers exist. First, at present no global strategy 
for the control or elimination of podoconiosis exists. 
Countries are implementing interventions based on 
experience from pilot projects. Normative guidance about 
the implementation of podoconiosis interventions with 
clear end goals must be provided by WHO. Although 
podoconiosis is mentioned on the WHO website,1 the lack 
of clear global strategies for podoconiosis has significantly 
limited advocacy and resource mobilisation.
Second, podoconiosis is one of the least financed 
neglected tropical diseases.13 To accelerate progress in 
the control and elimination of podoconiosis, increased 
investment is needed. While resources provided by donors 
and philanthropic organisations are critical, domestic 
financing of podoconiosis intervention should also be 
encouraged. Of the 32 countries considered endemic 
for podoconiosis, 22 are categorised as middle-income 
countries. These countries could ensure domestic resource 
allocation for sustainable financing of the prevention 
and treatment of podoconiosis. The elimination of 
podoconiosis aligns well with attainment of the UN’s 
Sustainable Development Goals (SDG).14 Podoconiosis 
interventions are a perfect example of health services 
requiring universal health coverage (SDG3). Responsive 
health systems with financial risk protection for affected 
individuals is critical. Nonetheless, the elimination of 
podoconiosis depends on the progress of other SDG goals. 
Determinants and drivers of podoconiosis are directly 
linked with other goals such as addressing poverty and 
social protection (SDG1), universal access to safe and 
affordable water and hygiene (SDG6), working and living 
conditions (SDG8), and inequalities (SDG10).14
Third, there is insufficient innovation in respect to new 
and better tools for podoconiosis prevention, control, 
and elimination.6 Point-of-care diagnosis, innovations 
which improve the outcome of morbidity management, 
and new tools for personal protection from soil 
exposure, including work-friendly and season-friendly 
footwear, are all important. To realise the elimination 
of podoconiosis, innovation that is faster and smarter 
than the current trend is crucial, as well as using multi-
disciplinary approaches to develop tools.
Fourth, reliable data for decision making is essential 
for effective use of available resources. Investment 
in distribution mapping and burden estimation in all 
endemic countries is crucial.3 Well-powered surveys 
will enable estimation of national disease burdens, but 
countries should also invest in surveillance systems 
and integrate indicators for podoconiosis into national 
health data platforms.
The first international conference on podoconiosis 
will take place on September 23, 2018, in Addis Ababa, 
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Ethiopia. The overall theme of the conference is 
“Research to implementation: a call for global action”, 
and the meeting aims to delineate a clear direction for 
podoconiosis intervention in endemic countries. The 
following outcomes are expected from the conference; 
first, the conference will be an important advocacy 
forum to showcase the key research and implementation 
advances achieved so far. Policy makers and programme 
planners will have the opportunity to share experiences. 
Second, resource mobilisation and domestic financing 
will be discussed. Third, a written commitment to global 
podoconiosis implementation will be generated. This will 
outline the guiding principles for the implementation 
and financing of podoconiosis programmes.
Elimination of podoconiosis is achievable within 
one generation. To achieve this goal, resources for 
translation of the available evidence into practice, for 
innovation and development of new tools, and for 
development of a comprehensive global strategy and 
case for investment are essential.
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